Webinar
16:00-17:00, 31 March 2022 (GMT+8 China Time)
There is more emphasis than ever before on biopharma innovation – a sentiment heightened by the speed at which the industry came together to develop vaccines for COVID-19 – setting new expectations for the future. With development comes fulfillment, and with biomanufacturing capacity at an all-time low, what infrastructure is needed to keep pace with innovation? This webinar will provide an overview of biopharma trends and technologies, and address challenges around supply chain, capacity and workforce, to ensure continued productivity, efficiency, and output in the biomanufacturing sector.
Killian O'Driscoll
Director of Projects
National Institute for Bioprocessing Research and Training (NIBRT)
Killian O’Driscoll is the Director of Projects at the National Institute for
Bioprocessing Research and Training (NIBRT). Killian is a Genetics Graduate from
Trinity College Dublin with an MSc in the Management of Innovation from the
University of London. He also is an Associate Lecturer in Project Management at
Dublin Business School
Prior to joining NIBRT, Killian worked with Microsoft European Operations Centre
as Senior Global Project Manager and with Ericsson Competence Development Centre
in the area of technology education and development.
Killian working closely with all stakeholders in the biopharmaceutical industry
has been involved in the successful establishment of NIBRT which has numerous
international accolades including ISPE Facility of The Year, Bioprocess
International Manufacturing Collaboration of the Decade and NIBRT is now
recognized as a global leader in biopharma research and training.
Eric Langer
President and Managing Partner
Bioplan Associates, Inc
Eric Langer, President and Managing Partner, has over 20 years’ experience in
biotechnology and life sciences international marketing, management, market
assessment, and publishing. He has held senior management and marketing
positions at biopharmaceutical supply companies.
He is an experienced biotechnology strategist, marketing practitioner,
publisher, and researcher. He has published, edited and authored numerous books,
reports, and major studies on topics including: Advances in Biopharmaceutical
Technology in China, Advances in Large-scale Biopharmaceutical Manufacturing,
Biopharmaceuticals in the US Market, cell culture reports, media, sera, tissue
engineering, stem cells, diagnostic products, blood products, genetics, DNA/PCR
purification, blood components, and many others.
He lectures extensively on marketing, pricing and channel management topics, and
teaches at Johns Hopkins University and American University: Biotechnology
Marketing, Marketing Management, Services Marketing, Advertising Strategy, and
Bioscience Communication.
In 1989 he co-founded BioPlan Associates, Inc. He has launched and managed
marketing programs for product lines ranging from $500k to $500 million.
Biopharmaceutical landscape outlook - what are the short and long-term impacts of COVID-19?
Rising trends and technologies – mRNA, immunology, and vaccines
Building flexible manufacturing networks and increasing capacity
Single-use tech availability
Training the workforce of the future















Ruby He
+86 21 33392436
Ruby.He@IMSinoexpo.com
HOSTED BUYERS